4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: May 7, 2019
Period of Report: May 1, 2019
Accession Number: 0001645470-19-000028

View Document ↗ View on SEC.gov ↗